(Q83919587)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16751806%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

title

Deregulated cyclin E promotes p53 loss of heterozygosity and tumorigenesis in the mouse mammary gland (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16751806%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16751806%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

author name string

Henze M

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16751806%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Lee JA

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16751806%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Osborn KG

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16751806%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Keck JM

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16751806%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Tedesco D

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16751806%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Bortner DM

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16751806%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Rosenberg MP

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16751806%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Reed SI

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16751806%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

publication date

5 June 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16751806%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16751806%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16751806%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

issue

55

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16751806%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

page(s)

7245-7259

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16751806%20AND%20SRC:MED&resulttype=core&format=json

Cyclin D1 in breast cancer

29 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209713

7 January 2021

DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209713

7 January 2021

Prognostic value of CCND1 gene status in sporadic breast tumours, as determined by real-time quantitative PCR assays

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209713

7 January 2021

Induction of mammary gland hyperplasia and carcinomas in transgenic mice expressing human cyclin E

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209713

7 January 2021

BRAF and FBXW7 (CDC4, FBW7, AGO, SEL10) mutations in distinct subsets of pancreatic cancer: potential therapeutic targets

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209713

7 January 2021

Requirement for a functional Rb-1 gene in murine development

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209713

7 January 2021

Turnover of cyclin E by the ubiquitin-proteasome pathway is regulated by cdk2 binding and cyclin phosphorylation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209713

7 January 2021

Immune response to cyclin B1 in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209713

7 January 2021

Differential gene expression in mouse mammary adenocarcinomas in the presence and absence of wild type p53

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209713

7 January 2021

Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209713

7 January 2021

Deregulation of cyclin E in human cells interferes with prereplication complex assembly

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209713

7 January 2021

Mutation of hCDC4 leads to cell cycle deregulation of cyclin E in cancer.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209713

7 January 2021

Loss of p27(Kip1) cooperates with cyclin E in T-cell lymphomagenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209713

7 January 2021

The oncogenic activity of cyclin E is not confined to Cdk2 activation alone but relies on several other, distinct functions of the protein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209713

7 January 2021

Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209713

7 January 2021

Puberty and genetic susceptibility to breast cancer in a case-control study in twins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209713

7 January 2021

In vivo analysis of mammary and non-mammary tumorigenesis in MMTV-cyclin D1 transgenic mice deficient in p53.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209713

7 January 2021

Cyclin E dysregulation and chromosomal instability in endometrial cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209713

7 January 2021

p53 regulates a G2 checkpoint through cyclin B1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209713

7 January 2021

Effects of an Rb mutation in the mouse

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209713

7 January 2021

Tumor spectrum analysis in p53-mutant mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209713

7 January 2021

Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209713

7 January 2021

Oncogenic potential of cyclin E in T-cell lymphomagenesis in transgenic mice: evidence for cooperation between cyclin E and Ras but not Myc

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209713

7 January 2021

Induction of centrosome amplification and chromosome instability in human bladder cancer cells by p53 mutation and cyclin E overexpression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209713

7 January 2021

The tumour suppressor protein p53 can repress transcription of cyclin B.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209713

7 January 2021

Frequent somatic mutations in PTEN and TP53 are mutually exclusive in the stroma of breast carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209713

7 January 2021

Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209713

7 January 2021

Overexpression of cyclin E protein is associated with specific mutation types in the p53 gene and poor survival in human breast cancer.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209713

7 January 2021

A mouse model for cyclin E-dependent genetic instability and tumorigenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209713

7 January 2021

Cyclin E-induced S phase without activation of the pRb/E2F pathway.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209713

7 January 2021

To cycle or not to cycle: a critical decision in cancer.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209713

7 January 2021

Archipelago regulates Cyclin E levels in Drosophila and is mutated in human cancer cell lines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209713

7 January 2021

Relationship between previous reproductive history and chemically induced mammary cancer in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209713

7 January 2021

Synergistic induction of centrosome hyperamplification by loss of p53 and cyclin E overexpression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209713

7 January 2021

Human cyclin E, a nuclear protein essential for the G1-to-S phase transition

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209713

7 January 2021

Novel potential ALL low-risk markers revealed by gene expression profiling with new high-throughput SSH-CCS-PCR.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209713

7 January 2021

Inactivation of hCDC4 can cause chromosomal instability

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209713

7 January 2021

Acceleration of the G1/S phase transition by expression of cyclins D1 and E with an inducible system

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209713

7 January 2021

Cyclin E associates with components of the pre-mRNA splicing machinery in mammalian cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209713

7 January 2021

pRb inactivation in mammary cells reveals common mechanisms for tumor initiation and progression in divergent epithelia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209713

7 January 2021

A CDK-independent function of mammalian Cks1: targeting of SCF(Skp2) to the CDK inhibitor p27Kip1.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209713

7 January 2021

Deregulated cyclin E induces chromosome instability

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209713

7 January 2021

Human F-box protein hCdc4 targets cyclin E for proteolysis and is mutated in a breast cancer cell line

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209713

7 January 2021

Refractoriness to mammary carcinogenesis in the parous mouse is reversible by hormonal stimulation induced by pituitary isografts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209713

7 January 2021

Refractoriness to mammary tumorigenesis in parous rats: is it caused by persistent changes in the hormonal environment or permanent biochemical alterations in the mammary epithelia?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209713

7 January 2021

Retention of wild-type p53 in tumors from p53 heterozygous mice: reduction of p53 dosage can promote cancer formation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209713

7 January 2021

Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209713

7 January 2021

The Cyclin E/Cdk2 Substrate and Cajal Body Component p220NPATActivates Histone Transcription through a Novel LisH-Like Domain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209713

7 January 2021

Multisite phosphorylation by Cdk2 and GSK3 controls cyclin E degradation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209713

7 January 2021

Sca-1(pos) cells in the mouse mammary gland represent an enriched progenitor cell population

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209713

7 January 2021

Immune recognition of cyclin B1 as a tumor antigen is a result of its overexpression in human tumors that is caused by non-functional p53

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209713

7 January 2021